Bioprocess Technology Market Size Report | Growth Forecasts 2028
[Research Report] The bioprocess technology market size was valued at US$ 30,897.49 million in 2022 and is projected to reach US$ 77,090.05 million by 2028; it is estimated to register a CAGR of 16.8% from 2023 to 2028.
Analyst’s Viewpoint
The advantages of bioprocess are using lower pressure, lower temperatures, and more conducive pH levels, and the entire process is renewable. Growing R&D spendings to introduce new drug compounds and increasing prevalence of chronic diseases. Stringent regulatory policies are the most impacting factors responsible for influential growth of the bioprocess technology market. Additionally, introducing advanced bioprocess technologies provide lucrative market opportunity for the overall market to grow exponentially during the forecast period. Further, emergence of Automated Real‐Time Flow Cytometry (ART‐FCM) acts as a future trend for the market to grow during 2023–2028. According to the segmentation profiled in the report, based on type segment, cell culture media bioprocess accounts a largest share; likewise, chromatography bioprocess is anticipated to register the highest CAGR during the forecast period (2023–2028). Furthermore, by modality, the single-use segment will account considerable share for the bioprocess technology during the forecast period. In terms of end user, the biopharmaceutical companies’ segment will dominate the bioprocess technology market growth during the forecast period.
Bioprocess technology is a critical part of biotechnology that deals with processes combining living matter or its components with nutrients that produce specialty chemicals, reagents, and biotherapeutics. Different stages associated with bioprocess technology involve substrates and media preparation, biocatalyst selection and optimization, volume production, downstream processing, purification, and final processing. Bioprocess technology is widely used, from food and pharmaceuticals to fuel and chemicals.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Bioprocess Technology Market: Strategic Insights
Market Size Value in US$ 30,897.49 million in 2022 Market Size Value by US$ 77,090.05 million by 2028 Growth rate CAGR of 16.8% from 2023 to 2028 Forecast Period 2023-2028 Base Year 2022
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Bioprocess Technology Market: Strategic Insights
| Market Size Value in | US$ 30,897.49 million in 2022 |
| Market Size Value by | US$ 77,090.05 million by 2028 |
| Growth rate | CAGR of 16.8% from 2023 to 2028 |
| Forecast Period | 2023-2028 |
| Base Year | 2022 |
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Market Insights
Growing R&D Spendings to Introduce New Drug Compounds
Pharmaceutical companies are spending huge sum in R&D to introduce new molecules with enhanced medical and commercial potency for various therapeutic applications. In the fiscal year 2019/2020, 16 pharmaceutical companies made it to the list of the world’s Top 50 companies in terms of total R&D investment. Novartis, Roche, Johnson & Johnson, Merck & Co, GlaxoSmithKline, and Pfizer are among the world’s Top 10 companies with high R&D investments.
R&D Investments by Major Pharmaceutical Companies
Company | R&D Investment in 2022 (US$ Million) | R&D Investment in 2021 (US$ Million) |
Gilead Sciences Inc | 27,305 | 27,281 |
Bristol-Myers Squibb Co | 46,159 | 46,385 |
Amgen Inc. | 26,323 | 25,979 |
Pfizer | 100,330 | 81,288 |
Merck & Co | 59,283 | 48,704 |
AbbVie Inc | 58,054 | 56,197 |
Note: The currency conversion rates have been considered wherever required.
Source: Annual Reports of Companies and The Insight Partners Analysis
The patent expiry of blockbuster molecules, a limited number of potential products in the pipeline, and the increasing demand for biologics have driven companies to adopt novel technologies, such as single-use bioprocessing technologies, in order to facilitate a quick cost-effective turnaround process for products. Single-use component and system manufacturers typically produce and assemble products in clean rooms to ensure they do not introduce harmful particulates and endotoxins into a bioprocess. Thus, high investments in R&D are made to introduce new drug compounds and aid in the development of bioprocessing technologies; these technologies support emerging biomanufacturing capabilities and related interoperability of raw materials, bioreactors, and unit operations.
Type-Based Insights
Based on type, the bioprocess technology market is segmented into cell culture media bioprocess, chromatography bioprocess, consumables & accessories, and others. The cell culture media bioprocess segment held a largest market share of bioprocess technology in 2022 whereas chromatography bioprocess is anticipated to register a highest CAGR during the forecast period (2023–2028).
Modality-Based Insights
Based on modality, the global bioprocess technology market is bifurcated into single use and multiple use. The single use segment accounted a larger market share for bioprocess technology in 2022. The multiple use segment is expected to grow at a higher CAGR during the forecast period.
End User-Based Insights
In terms of end user, the bioprocess technology market is categorized into academic & medical institutions, biopharmaceutical companies, research laboratories, and others. The biopharmaceutical companies segment held a largest market share in 2022, whereas academic & medical institutions is expected to register a higher CAGR during the forecast period.
Regional Analysis
North America dominated the bioprocess technology market accounting maximum share. The bioprocess technology market growth in this region is attributed due to the presence of large players launching innovative products (particularly related to bioprocess technology), growing product introduction in the region, and technological advancements in bioprocess technology. In North America, the US records maximum share for the bioprocess technology. According to the Food and Drug Administration (FDA) report, over 30 million people in the US suffer from ~7,000 rare diseases, accounting for life-threatening conditions with low treatment options. Drug, biological, and device development in the treatment of rare diseases is challenging due to a lack of understanding of the history of rare diseases and difficulty in conducting clinical trials. Therefore, the growth of bioprocess technologies such as gene and cell therapies (CGTs) and specialty pharmaceuticals represent a radical shift in the treatment of rare diseases. For example, CGTs have revealed significant health benefits than formulated drugs for treating rare diseases. In the US, more than 900 investigational new drug (IND) applications targeting gene therapy products are underway. Also, 10-20 gene therapies are approved annually by the FDA. Likewise, in August 2022, the FDA approved Bluebird Bio's "Zynteglo (betibeglogene autotemcel)." It was the most expensive single-application drug approval in the US intended for the treatment of a rare neurological disorder—cerebral adrenoleukodystrophy (CALD).
Likewise, Asia Pacific region will account highest CAGR for the bioprocess technology market. Among Asia Pacific region, China will hold considerable market share for the bioprocess technology market. The bioprocessing capacity globally has increased at an average of 12% since the past decade, as per the BioPlan Associates Top 1000 Biofacility Index and Biomanufacturers Database report. China is well positioned as a global participant in markets with both small and large-molecule drugs, accounting for second and third position, respectively, worldwide. Also, China is home to several developers of cell and gene therapy due to China's base for contract development and manufacturing organizations (CDMOs), accounting for ~25% of the country's bioproduction capacity. Therefore, China has considerable biomanufacturing capabilities but strict adherence to the global GMP standards that build confidence in the biologics' safety and effectiveness.
Country | Biomanufacturing Facility (L) | Global Capacity (%) | Estimated Capacity CAGR (%) |
China | 1.77 million | 10.2 | 15-20 |
Source: Global comparison of biomanufacturing capacity; data from the BioPlan Associates Top 1000 Biofacility Index and Biomanufacturers Database (CAGR = compound annual growth rate).
Bioprocess Technology Market Report Scope
Merck KGaA, Sartorius AG, Thermo Fisher Scientific Inc, Corning Inc, STAMM Biotech, Lonza Group AG, Eppendorf SE, Repligen Corp, Danaher Corp, and BioPharma Dynamics Ltd are among the leading players operating in the global bioprocess technology market growth. Several other essential market players were analyzed for a holistic view of the market and its ecosystem. The report provides detailed market insights, which help the key players strategize their market growth. A few developments are mentioned below:
- In June 2022, Merck has entered a collaboration with Agilent Technologies to advance Process Analytical Technologies (PAT). PAT, which is strongly encouraged by global regulatory authorities, is a key enabler for real-time release and Bioprocessing 4.0.
- In March 2020, Sartorius launched BIOSTAT STR Generation 3 single-use bioreactor and BIOBRAIN automation platform to introduce innovations that will change the field of biopharmaceutical process development and manufacturing. Biostat STR simplifies biologics production.
Company Profiles
- Merck KGaA
- Sartorius AG
- Thermo Fisher Scientific Inc
- Corning Inc
- STAMM Biotech
- Lonza Group AG
- Eppendorf SE
- Repligen Corp
- Danaher Corp
- BioPharma Dynamics Ltd
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Type, Modality, and End User
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States
Frequently Asked Questions
Bioprocessing is the process that utilizes complete living cells or components (e.g., bacteria, enzymes, and proteins) to obtain desired products. The process is commonly known as fermentation. The entire process is divided into three stages: upstream process, fermentation, and downstream process. The upstream process involves preparation of liquid media, separation of particulate and inhibitory chemicals through sterilization and air purification. Additionally, fermentation involves the conversion of substrate to obtain desired products through biological agents such as microorganisms. Furthermore, downstream processing involves separation of cells from the fermentation broth, purification and concentration of desired products and waste disposal or recycle method.
The growing R&D spendings to introduce new drug compounds, and increasing prevalence of chronic diseases. However, stringent regulatory policies are restricting the market growth.
Based on type, cell culture media bioprocess took the forefront leaders in the worldwide market by accounting largest share in 2022 and is expected to continue to do so till the forecast period.
Global bioprocess technology market is segmented by region into North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. In North America, the U.S. held the largest market share for bioprocess technology market. The US is expected to hold the largest share in the bioprocess technology market during the forecast period. The presence of top players and favorable regulations related to product approvals coupled with commercializing new products are the contributing factors for the regional growth. Additionally, the increasing number of technological advancements is the key factor responsible for the Asia Pacific regional growth in the coming years.
Merck KGaA, Sartorius AG, Thermo Fisher Scientific Inc, Corning Inc, STAMM Biotech, Lonza Group AG, Eppendorf SE, Repligen Corp, Danaher Corp, BioPharma Dynamics Ltd; are among the leading companies operating in the global bioprocess technology market
The single use segment dominated the global bioprocess technology market.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Bioprocess Technology Market – by Type
1.3.2 Global Bioprocess Technology Market – by Modality
1.3.3 Global Bioprocess Technology Market – by End User
1.3.4 Global Bioprocess Technology Market – by Geography
2. Bioprocess Technology Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Bioprocess Technology Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America PEST Analysis
4.2.2 Europe PEST Analysis
4.2.3 Asia Pacific PEST Analysis
4.2.4 South & Central America PEST Analysis
4.2.5 Middle East & Africa PEST Analysis
4.3 Expert’s Opinion
5. Bioprocess Technology Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Growing R&D Spendings to Introduce New Drug Compounds
5.1.2 Increasing Prevalence of Chronic Diseases
5.2 Market Restraints
5.2.1 Stringent Regulatory Policies
5.3 Market Opportunities
5.3.1 Introducing Advanced Bioprocess Technologies
5.4 Future Trends
5.4.1 Introduction of Automated Real?Time Flow Cytometry (ART?FCM)
5.5 Impact Analysis
6. Bioprocess Technology Market – Global Analysis
6.1 Global Bioprocess Technology Market Revenue Forecast and Analysis
6.2 Global Bioprocess Technology Market, by Geography – Forecast and Analysis
6.3 Market Positioning of Key Players
7. Global Bioprocess Technology Market – Revenue and Forecast to 2028 – by Type
7.1 Overview
7.2 Bioprocess Technology Market Revenue Share, by Type 2022 & 2028 (%)
7.3 Cell Culture Media Bioprocess
7.3.1 Overview
7.3.2 Cell Culture Media Bioprocess: Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Chromatographic Bioprocess
7.4.1 Overview
7.4.2 Chromatographic Bioprocess: Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Consumables & Accessories
7.5.1 Overview
7.5.2 Consumables & Accessories: Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
7.6 Others
7.6.1 Overview
7.6.2 Others: Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
8. Global Bioprocess Technology Market Analysis and Forecasts to 2028 – by Modality
8.1 Overview
8.2 Global Bioprocess Technology Market, by Modality 2022 & 2028 (%)
8.3 Single Use
8.3.1 Overview
8.3.2 Single Use: Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Multiple Use
8.4.1 Overview
8.4.2 Multiple Use: Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
9. Global Bioprocess Technology Market – Revenue and Forecast to 2028 – by End User
9.1 Overview
9.2 Bioprocess Technology Market Revenue Share, by End User 2022 & 2028 (%)
9.3 Academic & Medical Institutions
9.3.1 Overview
9.3.2 Academic & Medical Institutions: Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Biopharmaceutical Companies
9.4.1 Overview
9.4.2 Biopharmaceutical Companies: Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Research Laboratories
9.5.1 Overview
9.5.2 Research Laboratories: Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others: Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
10. Bioprocess Technology Market – Revenue and Forecast to 2028 – Geographic Analysis
10.1 North America: Bioprocess Technology Market
10.1.1 Overview
10.1.2 North America: Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
10.1.3 North America: Bioprocess Technology Market, by Type, 2019–2028 (US$ Million)
10.1.4 North America: Bioprocess Technology Market, by Modality, 2019–2028 (US$ Million)
10.1.5 North America: Bioprocess Technology Market, by End User, 2019–2028 (US$ Million)
10.1.5.1 US: Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
10.1.5.1.1 Overview
10.1.5.1.2 US: Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
10.1.5.1.3 US: Bioprocess Technology Market, by Type, 2019–2028 (US$ Million)
10.1.5.1.4 US: Bioprocess Technology Market, by Modality, 2019–2028 (US$ Million)
10.1.5.1.5 US: Bioprocess Technology Market, by End User, 2019–2028 (US$ Million)
10.1.5.2 Canada: Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
10.1.5.2.1 Overview
10.1.5.2.2 Canada: Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
10.1.5.2.3 Canada: Bioprocess Technology Market, by Type, 2019–2028 (US$ Million)
10.1.5.2.4 Canada: Bioprocess Technology Market, by Modality, 2019–2028 (US$ Million)
10.1.5.2.5 Canada: Bioprocess Technology Market, by End User, 2019–2028 (US$ Million)
10.1.5.3 Mexico: Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
10.1.5.3.1 Overview
10.1.5.3.2 Mexico: Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
10.1.5.3.3 Mexico: Bioprocess Technology Market, by Type, 2019–2028 (US$ Million)
10.1.5.3.4 Mexico: Bioprocess Technology Market, by Modality, 2019–2028 (US$ Million)
10.1.5.3.5 Mexico: Bioprocess Technology Market, by End User, 2019–2028 (US$ Million)
10.2 Europe: Bioprocess Technology Market
10.2.1 Overview
10.2.2 Europe: Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
10.2.3 Europe: Bioprocess Technology Market, by Type, 2019–2028 (US$ Million)
10.2.4 Europe: Bioprocess Technology Market, by Modality, 2019–2028 (US$ Million)
10.2.5 Europe: Bioprocess Technology Market, by End User, 2019–2028 (US$ Million)
10.2.6 Europe: Bioprocess Technology Market, by Country, 2022 & 2028 (%)
10.2.6.1 Germany: Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
10.2.6.1.1 Overview
10.2.6.1.2 Germany: Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
10.2.6.1.3 Germany: Bioprocess Technology Market, by Type, 2019–2028 (US$ Million)
10.2.6.1.4 Germany: Bioprocess Technology Market, by Modality, 2019–2028 (US$ Million)
10.2.6.1.5 Germany: Bioprocess Technology Market, by End User, 2019–2028 (US$ Million)
10.2.6.2 UK: Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
10.2.6.2.1 Overview
10.2.6.2.2 UK: Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
10.2.6.2.3 UK: Bioprocess Technology Market, by Type, 2019–2028 (US$ Million)
10.2.6.2.4 UK: Bioprocess Technology Market, by Modality, 2019–2028 (US$ Million)
10.2.6.2.5 UK: Bioprocess Technology Market, by End User, 2019–2028 (US$ Million)
10.2.6.3 France: Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
10.2.6.3.1 Overview
10.2.6.3.2 France: Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
10.2.6.3.3 France: Bioprocess Technology Market, by Type, 2019–2028 (US$ Million)
10.2.6.3.4 France: Bioprocess Technology Market, by Modality, 2019–2028 (US$ Million)
10.2.6.3.5 France: Bioprocess Technology Market, by End User, 2019–2028 (US$ Million)
10.2.6.4 Italy: Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
10.2.6.4.1 Overview
10.2.6.4.2 Italy: Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
10.2.6.4.3 Italy: Bioprocess Technology Market, by Type, 2019–2028 (US$ Million)
10.2.6.4.4 Italy: Bioprocess Technology Market, by Modality, 2019–2028 (US$ Million)
10.2.6.4.5 Italy: Bioprocess Technology Market, by End User, 2019–2028 (US$ Million)
10.2.6.5 Spain: Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
10.2.6.5.1 Overview
10.2.6.5.2 Spain: Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
10.2.6.5.3 Spain: Bioprocess Technology Market, by Type, 2019–2028 (US$ Million)
10.2.6.5.4 Spain: Bioprocess Technology Market, by Modality, 2019–2028 (US$ Million)
10.2.6.5.5 Spain: Bioprocess Technology Market, by End User, 2019–2028 (US$ Million)
10.2.6.6 Rest of Europe: Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
10.2.6.6.1 Overview
10.2.6.6.2 Rest of Europe: Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
10.2.6.6.3 Rest of Europe: Bioprocess Technology Market, by Type, 2019–2028 (US$ Million)
10.2.6.6.4 Rest of Europe: Bioprocess Technology Market, by Modality, 2019–2028 (US$ Million)
10.2.6.6.5 Rest of Europe: Bioprocess Technology Market, by End User, 2019–2028 (US$ Million)
10.3 Asia Pacific: Bioprocess Technology Market
10.3.1 Overview
10.3.2 Asia Pacific: Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
10.3.3 Asia Pacific: Bioprocess Technology Market, by Type, 2019–2028 (US$ Million)
10.3.4 Asia Pacific: Bioprocess Technology Market, by Modality, 2019–2028 (US$ Million)
10.3.5 Asia Pacific: Bioprocess Technology Market, by End User, 2019–2028 (US$ Million)
10.3.6 Asia Pacific: Bioprocess Technology Market, by Country, 2022 & 2028 (%)
10.3.6.1 China: Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
10.3.6.1.1 Overview
10.3.6.1.2 China: Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
10.3.6.1.3 China: Bioprocess Technology Market, by Type, 2019–2028 (US$ Million)
10.3.6.1.4 China: Bioprocess Technology Market, by Modality, 2019–2028 (US$ Million)
10.3.6.1.5 China Bioprocess Technology Market, by End User, 2019–2028 (US$ Million)
10.3.6.2 Japan: Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
10.3.6.2.1 Overview
10.3.6.2.2 Japan: Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
10.3.6.2.3 Japan: Bioprocess Technology Market, by Type, 2019–2028 (US$ Million)
10.3.6.2.4 Japan: Bioprocess Technology Market, by Modality, 2019–2028 (US$ Million)
10.3.6.2.5 Japan: Bioprocess Technology Market, by End User, 2019–2028 (US$ Million)
10.3.6.3 India: Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
10.3.6.3.1 Overview
10.3.6.3.2 India: Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
10.3.6.3.3 India: Bioprocess Technology Market, by Type, 2019–2028 (US$ Million)
10.3.6.3.4 India: Bioprocess Technology Market, by Modality, 2019–2028 (US$ Million)
10.3.6.3.5 India: Bioprocess Technology Market, by End User, 2019–2028 (US$ Million)
10.3.6.4 South Korea: Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
10.3.6.4.1 Overview
10.3.6.4.2 South Korea: Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
10.3.6.4.3 South Korea: Bioprocess Technology Market, by Type, 2019–2028 (US$ Million)
10.3.6.4.4 South Korea: Bioprocess Technology Market, by Modality, 2019–2028 (US$ Million)
10.3.6.4.5 South Korea: Bioprocess Technology Market, by End User, 2019–2028 (US$ Million)
10.3.6.5 Australia: Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
10.3.6.5.1 Overview
10.3.6.5.2 Australia: Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
10.3.6.5.3 Australia: Bioprocess Technology Market, by Type, 2019–2028 (US$ Million)
10.3.6.5.4 Australia: Bioprocess Technology Market, by Modality, 2019–2028 (US$ Million)
10.3.6.5.5 Australia: Bioprocess Technology Market, by End User, 2019–2028 (US$ Million)
10.3.6.6 Rest of Asia Pacific: Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
10.3.6.6.1 Overview
10.3.6.6.2 Rest of Asia Pacific: Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
10.3.6.6.3 Rest of Asia Pacific: Bioprocess Technology Market, by Type, 2019–2028 (US$ Million)
10.3.6.6.4 Rest of Asia Pacific: Bioprocess Technology Market, by Modality, 2019–2028 (US$ Million)
10.3.6.6.5 Rest of Asia Pacific: Bioprocess Technology Market, by End User, 2019–2028 (US$ Million)
10.4 Middle East & Africa Bioprocess Technology Market
10.4.1 Overview
10.4.2 Middle East & Africa: Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
10.4.3 Middle East & Africa: Bioprocess Technology Market, by Type, 2019–2028 (US$ Million)
10.4.4 Middle East & Africa: Bioprocess Technology Market, by Modality, 2019–2028 (US$ Million)
10.4.5 Middle East & Africa Bioprocess Technology Market, by End User, 2019–2028 (US$ Million)
10.4.6 Middle East & Africa: Bioprocess Technology Market, by Country, 2022 & 2028 (%)
10.4.6.1 UAE: Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
10.4.6.1.1 Overview
10.4.6.1.2 UAE: Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
10.4.6.1.3 UAE: Bioprocess Technology Market, by Type, 2019–2028 (US$ Million)
10.4.6.1.4 UAE: Bioprocess Technology Market, by Modality, 2019–2028 (US$ Million)
10.4.6.1.5 UAE Bioprocess Technology Market, by End User, 2019–2028 (US$ Million)
10.4.6.2 Saudi Arabia: Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
10.4.6.2.1 Overview
10.4.6.2.2 Saudi Arabia: Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
10.4.6.2.3 Saudi Arabia: Bioprocess Technology Market, by Type, 2019–2028 (US$ Million)
10.4.6.2.4 Saudi Arabia: Bioprocess Technology Market, by Modality, 2019–2028 (US$ Million)
10.4.6.2.5 Saudi Arabia Bioprocess Technology Market, by End User, 2019–2028 (US$ Million)
10.4.6.3 South Africa: Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
10.4.6.3.1 Overview
10.4.6.3.2 South Africa: Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
10.4.6.3.3 South Africa: Bioprocess Technology Market, by Type, 2019–2028 (US$ Million)
10.4.6.3.4 South Africa: Bioprocess Technology Market, by Modality, 2019–2028 (US$ Million)
10.4.6.3.5 South Africa Bioprocess Technology Market, by End User, 2019–2028 (US$ Million)
10.4.6.4 Rest of Middle East & Africa: Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
10.4.6.4.1 Overview
10.4.6.4.2 Rest of Middle East & Africa: Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
10.4.6.4.3 Rest of Middle East & Africa: Bioprocess Technology Market, by Type, 2019–2028 (US$ Million)
10.4.6.4.4 Rest of Middle East & Africa: Bioprocess Technology Market, by Modality, 2019–2028 (US$ Million)
10.4.6.4.5 Rest of Middle East & Africa Bioprocess Technology Market, by End User, 2019–2028 (US$ Million)
10.5 South & Central America Bioprocess Technology Market
10.5.1 Overview
10.5.2 South & Central America: Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
10.5.3 South & Central America: Bioprocess Technology Market, by Type, 2019–2028 (US$ Million)
10.5.4 South & Central America: Bioprocess Technology Market, by Modality, 2019–2028 (US$ Million)
10.5.5 South & Central America: Bioprocess Technology Market, by End User, 2019–2028 (US$ Million)
10.5.6 South & Central America: Bioprocess Technology Market, by Country, 2022 & 2028 (%)
10.5.6.1 Brazil: Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
10.5.6.1.1 Overview
10.5.6.1.2 Brazil: Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
10.5.6.1.3 Brazil: Bioprocess Technology Market, by Type, 2019–2028 (US$ Million)
10.5.6.1.4 Brazil: Bioprocess Technology Market, by Modality, 2019–2028 (US$ Million)
10.5.6.1.5 Brazil: Bioprocess Technology Market, by End User, 2019–2028 (US$ Million)
10.5.6.2 Argentina: Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
10.5.6.2.1 Overview
10.5.6.2.2 Argentina: Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
10.5.6.2.3 Argentina: Bioprocess Technology Market, by Type, 2019–2028 (US$ Million)
10.5.6.2.4 Argentina: Bioprocess Technology Market, by Modality, 2019–2028 (US$ Million)
10.5.6.2.5 Argentina: Bioprocess Technology Market, by End User, 2019–2028 (US$ Million)
10.5.6.3 Rest of South & Central America: Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
10.5.6.3.1 Overview
10.5.6.3.2 Rest of South & Central America: Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
10.5.6.3.3 Rest of South & Central America: Bioprocess Technology Market, by Type, 2019–2028 (US$ Million)
10.5.6.3.4 Rest of South & Central America: Bioprocess Technology Market, by Modality, 2019–2028 (US$ Million)
10.5.6.3.5 Rest of South & Central America: Bioprocess Technology Market, by End User, 2019–2028 (US$ Million)
11. Impact Of COVID-19 Pandemic on Bioprocess Technology Market
11.1 North America: Impact Assessment of COVID-19 Pandemic
11.2 Europe: Impact Assessment of COVID-19 Pandemic
11.3 Asia Pacific: Impact Assessment of COVID-19 Pandemic
11.4 Middle East & Africa: Impact Assessment of COVID-19 Pandemic
11.5 South & Central America: Impact Assessment of COVID-19 Pandemic
12. Bioprocess Technology Market – Industry Landscape
12.1 Overview
12.2 Growth Strategies in Bioprocess Technology Market
12.3 Organic Growth Strategies
12.3.1 Overview
12.4 Inorganic Growth Strategies
12.4.1 Overview
13. Company Profiles
13.1 Merck KGaA
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Sartorius AG
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Thermo Fisher Scientific Inc
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Corning Inc
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 STAMM Biotech
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Lonza Group AG
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Eppendorf SE
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Repligen Corp
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Danaher Corp
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 BioPharma Dynamics Ltd
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. R&D Investments by Major Pharmaceutical Companies
Table 2. North America Bioprocess Technology Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 3. North America Bioprocess Technology Market, by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 4. North America Bioprocess Technology Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 5. US Bioprocess Technology Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 6. US Bioprocess Technology Market, by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 7. US Bioprocess Technology Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 8. Canada Bioprocess Technology Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 9. Canada Bioprocess Technology Market, by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 10. Canada Bioprocess Technology Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 11. Mexico Bioprocess Technology Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 12. Mexico Bioprocess Technology Market, by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 13. Mexico Bioprocess Technology Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 14. Europe Bioprocess Technology Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 15. Europe Bioprocess Technology Market, by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 16. Europe Bioprocess Technology Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 17. Germany Bioprocess Technology Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 18. Germany Bioprocess Technology Market, by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 19. Germany Bioprocess Technology Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 20. UK Bioprocess Technology Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 21. UK Bioprocess Technology Market, by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 22. UK Bioprocess Technology Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 23. France Bioprocess Technology Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 24. France Bioprocess Technology Market, by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 25. France Bioprocess Technology Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 26. Italy Bioprocess Technology Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 27. Italy Bioprocess Technology Market, by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 28. Italy Bioprocess Technology Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 29. Spain Bioprocess Technology Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 30. Spain Bioprocess Technology Market, by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 31. Spain Bioprocess Technology Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 32. Rest of Europe Bioprocess Technology Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 33. Rest of Europe Bioprocess Technology Market, by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 34. Rest of Europe Bioprocess Technology Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 35. Asia Pacific Bioprocess Technology Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 36. Asia Pacific Bioprocess Technology Market, by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 37. Asia Pacific Bioprocess Technology Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 38. China Bioprocess Technology Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 39. China Bioprocess Technology Market, by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 40. China Bioprocess Technology Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 41. Japan Bioprocess Technology Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 42. Japan Bioprocess Technology Market, by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 43. Japan Bioprocess Technology Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 44. India Bioprocess Technology Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 45. India Bioprocess Technology Market, by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 46. India Bioprocess Technology Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 47. South Korea Bioprocess Technology Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 48. South Korea Bioprocess Technology Market, by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 49. South Korea Bioprocess Technology Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 50. Australia Bioprocess Technology Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 51. Australia Bioprocess Technology Market, by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 52. Australia Bioprocess Technology Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 53. Rest of Asia Pacific Bioprocess Technology Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 54. Rest of Asia Pacific Bioprocess Technology Market, by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 55. Rest of Asia Pacific Bioprocess Technology Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 56. Middle East & Africa Bioprocess Technology Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 57. Middle East & Africa Bioprocess Technology Market, by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 58. Middle East & Africa Bioprocess Technology Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 59. UAE Bioprocess Technology Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 60. UAE Bioprocess Technology Market, by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 61. UAE Bioprocess Technology Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 62. Saudi Arabia Bioprocess Technology Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 63. Saudi Arabia Bioprocess Technology Market, by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 64. Saudi Arabia Bioprocess Technology Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 65. South Africa Bioprocess Technology Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 66. South Africa Bioprocess Technology Market, by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 67. South Africa Bioprocess Technology Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 68. Rest of Middle East & Africa Bioprocess Technology Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 69. Rest of Middle East & Africa Bioprocess Technology Market, by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 70. Rest of Middle East & Africa Bioprocess Technology Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 71. South & Central America Bioprocess Technology Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 72. South & Central America Bioprocess Technology Market, by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 73. South & Central America Bioprocess Technology Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 74. Brazil Bioprocess Technology Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 75. Brazil Bioprocess Technology Market, by Modality– Revenue and Forecast to 2028 (US$ Million)
Table 76. Brazil Bioprocess Technology Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 77. Argentina Bioprocess Technology Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 78. Argentina Bioprocess Technology Market, by Modality– Revenue and Forecast to 2028 (US$ Million)
Table 79. Argentina Bioprocess Technology Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 80. Rest of South & Central America Bioprocess Technology Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 81. Rest of South & Central America Bioprocess Technology Market, by Modality– Revenue and Forecast to 2028 (US$ Million)
Table 82. Rest of South & Central America Bioprocess Technology Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 83. Recent Organic Growth Strategies in Bioprocess Technology Market
Table 84. Recent Inorganic Growth Strategies in the Bioprocess Technology Market
Table 85. Glossary of Terms
LIST OF FIGURES
Figure 1. Bioprocess Technology Market Segmentation
Figure 2. Bioprocess Technology Market, by Geography
Figure 3. Global Bioprocess Technology Market Overview
Figure 4. Consumables and Accessories Segment Held Largest Share of Type Segment in Bioprocess Technology Market
Figure 5. Asia Pacific Expected to Show Remarkable Growth During Forecast Period
Figure 6. Bioprocess Technology Market, by Geography (US$ Million)
Figure 7. Global Bioprocess Technology Market – Leading Country Markets (US$ Million)
Figure 8. Global Bioprocess Technology Market – Industry Landscape
Figure 9. North America: PEST Analysis
Figure 10. Europe: PEST Analysis
Figure 11. Asia Pacific: PEST Analysis
Figure 12. South & Central America: PEST Analysis
Figure 13. Middle East & Africa: PEST Analysis
Figure 14. Experts’ Opinion
Figure 15. Global Bioprocess Technology Market – Revenue Forecast and Analysis – 2020–2028
Figure 16. Global Bioprocess Technology Market, by Geography – Forecast and Analysis (2022–2028)
Figure 17. Market Positioning of Key Players in Bioprocess Technology Market
Figure 18. Bioprocess Technology Market Revenue Share, by Type 2022 & 2028 (%)
Figure 19. Cell Culture Media Bioprocess: Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 20. Chromatographic Bioprocess: Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. Consumables & Accessories: Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. Others: Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. Global Bioprocess Technology Market, by Modality 2022 & 2028 (%)
Figure 24. Single Use: Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25. Multiple Use: Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26. Bioprocess Technology Market Revenue Share, by End User 2022 & 2028 (%)
Figure 27. Academic & Medical Institutions: Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 28. Biopharmaceutical Companies: Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 29. Research Laboratories: Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 30. Others: Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 31. North America: Bioprocess Technology Market, by Key Country – Revenue (2022) (US$ Million)
Figure 32. North America Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 33. North America: Bioprocess Technology Market, by Country, 2022 & 2028 (%)
Figure 34. US: Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 35. Canada: Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 36. Mexico: Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 37. Europe: Bioprocess Technology Market, by Key Country – Revenue (2022) (US$ Million)
Figure 38. Europe Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 39. Europe: Bioprocess Technology Market, by Country, 2022& 2028 (%)
Figure 40. Germany: Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 41. UK: Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 42. France: Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 43. Italy: Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 44. Spain: Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 45. Rest of Europe: Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 46. Asia Pacific: Bioprocess Technology Market, by Key Country – Revenue (2022) (US$ Million)
Figure 47. Asia Pacific Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 48. China: Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 49. Japan: Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 50. India: Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 51. South Korea: Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 52. Australia: Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 53. Rest of Asia Pacific: Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 54. Middle East & Africa: Bioprocess Technology Market, by Key Country – Revenue (2022) (US$ Million)
Figure 55. Middle East & Africa Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 56. UAE: Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 57. Saudi Arabia: Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 58. South Africa: Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 59. Rest of Middle East & Africa: Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 60. South & Central America: Bioprocess Technology Market, by Key Country – Revenue (2022) (US$ Million)
Figure 61. South & Central America Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 62. South & Central America: Bioprocess Technology Market, by Country, 2022 & 2028 (%)
Figure 63. Brazil: Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 64. Argentina: Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 65. Rest of South & Central America: Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 66. Impact of COVID-19 Pandemic on North American Country Markets
Figure 67. Impact of COVID-19 Pandemic in European Country Markets
Figure 68. Impact of COVID-19 Pandemic in Asia Pacific Country Markets
Figure 69. Impact of COVID-19 Pandemic in Middle East & Africa Country Markets
Figure 70. Impact of COVID-19 Pandemic on South & Central American Country Markets
Figure 71. Growth Strategies in Bioprocess Technology Market
The List of Companies - Bioprocess Technology Market
- Merck KGaA
- Sartorius AG
- Thermo Fisher Scientific Inc
- Corning Inc
- STAMM Biotech
- Lonza Group AG
- Eppendorf SE
- Repligen Corp
- Danaher Corp
- BioPharma Dynamics Ltd
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For